News & Updates
Filter by Specialty:
Early addition of cerebrolysin to reperfusion therapy reduces haemorrhagic transformation after ischaemic stroke
A prospective, randomized, multicentre pilot study finds that early addition of cerebrolysin to reperfusion therapy is safe and significantly reduces the rate of haemorrhagic transformation (HT) after acute ischaemic stroke (AIS).
Early addition of cerebrolysin to reperfusion therapy reduces haemorrhagic transformation after ischaemic stroke
12 Apr 2023
Exergaming improves neuronal activity and executive function in older adults with dementia
Findings of a small randomized trial in older adults with moderate dementia suggest that exergaming may be associated with greater improvements in brain neuronal activity and enhanced executive function task performance than regular aerobic exercise.
Exergaming improves neuronal activity and executive function in older adults with dementia
12 Apr 2023
Ripretinib improves survival in advanced gastrointestinal stromal tumours
Treatment with ripretinib provides a prolonged clinical and radiological benefit in patients with advanced gastrointestinal stromal tumours (GIST) within the expanded access program (EAP) in the UK, as shown in a study presented at the ESMO Sarcoma and Rare Cancers Congress 2023 in Lugano, Switzerland.
